Pharmaceutical technologies fast transferring to China

Published: 2003-03-24 06:59:00

Updated: 2003-03-24 06:59:00

The Korea New Drug R&D Association (KNDRDA) and the Chinese National Health Science and Technology Industrial Base (CNHSTIB) have made a visible treaty framework for the pharmaceutical technology transfer under the title of "Korea and China Interbiz Medical and Bio Industrial Partnering Forum", s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK